Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our October issue of Pharmaceutical Executive
FEATURES

Cover Feature
Corey McCann: PDT Pioneer
Julian Upton
Corey McCann, president and CEO of Pear Therapeutics, discusses how the prescription digital therapeutics space has evolved in a decade from disruptive concept to an exciting, growing market.
Download the digital issue


ADVERTISEMENT
Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
Wednesday, November 20, 2019 at 10am EST| 9am CST| 3pm GMT| 4pm CET
Register Now
Special Feature
Tech Tour for the C-Suite

Pharm Exec Editors
Amid new findings on today’s C-suite mood and approach to digital transformation, experts—in a panel discussion and wider examinations by Pharm Exec editors—explore the intersection of data and technology and the areas that must evolve to meet the digital health demands of tomorrow.
Download the digital issue
ADVERTISEMENT
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
Register Now
Interview
Olivier Laureau, Servier: Free to Grow, Innovate

PharmaBoardroom
French independent pharma Servier Group, led by president Olivier Laureau, is uniquely positioned to capitalize on new opportunities for expansion and stay true to its R&D and patient-focused mission.
Download the digital issue
ADVERTISEMENT
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 29, 2019 at 11am JST
Register Now
Policy Sync-Up
The Drug Importation Conundrum

Christopher R. Smith
Coexisting with the DSCSA may hinder new legislative efforts.
Download the digital issue
ADVERTISEMENT
Launch Strategies: Trends and Challenges for Biotech Companies
Wednesday, October 23, 2019 at 10am EDT
Register Now

ALSO IN THIS ISSUE
It Starts with a Scribble
Lisa Henderson
Our quest to make sense of a complex future data ecosystem in pharma …Read more

Data Integrity Scandal Prompts FDA Probe
Jill Wechsler
Lapse spotlights wider actions to ensure data accuracy  …Read more

Where Does the European Drug Industry Go from Here?
Reflector
Change in season ushers in a pivotal period for pharma in shaping the direction of EU healthcare  …Read more

ADVERTISEMENT
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST
Register Now
 
Download the
issue:
 
image
 

WEBCASTS
Launching Medical Devices in the Japanese Market: How to Navigate Regulatory and Reimbursement Approval
Japan Oncology Market: Best in Class Practices for Advancing Patient Outcomes
Launch Strategies: Trends and Challenges for Biotech Companies
Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-time Data Driven Compliance
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
Patient Adherence: A Hard Pill to Swallow?

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.

Twitter LinkedIn